1 | ethnic | 1,903 |
2 | seasonal | 1,479 |
3 | geographic | 1,010 |
4 | geographical | 815 |
5 | racial | 786 |
6 | avian | 474 |
7 | hydroxyl | 453 |
8 | racial/ethnic | 341 |
9 | taxonomic | 247 |
10 | 3'-untranslated | 95 |
11 | electron-withdrawing | 59 |
12 | interspecific | 59 |
13 | intraspecific | 52 |
14 | race/ethnic | 43 |
15 | latitudinal | 39 |
16 | transatlantic | 32 |
17 | 5'-untranslated | 30 |
18 | age-sex | 30 |
19 | electron-donating | 30 |
20 | racial-ethnic | 30 |
21 | ethnic/racial | 21 |
22 | antibody-drug | 20 |
23 | superordinate | 19 |
24 | biogeographic | 18 |
25 | oxygen-containing | 17 |
26 | rural-urban | 17 |
27 | oxygen-free | 16 |
28 | valent | 16 |
29 | methoxyl | 15 |
30 | yangming | 15 |
31 | livedo | 14 |
32 | nicobar | 14 |
33 | age-gender | 13 |
34 | evidence-practice | 13 |
35 | tyrosyl | 13 |
36 | age/sex | 12 |
37 | group-related | 12 |
38 | meth-oxy | 12 |
39 | floristic | 11 |
40 | non-sleep | 11 |
41 | lased | 10 |
42 | ethnical | 9 |
43 | race-ethnic | 9 |
44 | varietal | 9 |
45 | crenarchaeotal | 8 |
46 | ethnic-based | 8 |
47 | hiv-status | 8 |
48 | low-probability | 8 |
49 | monocotyledonous | 8 |
50 | race-sex | 8 |
51 | toxin-treated | 8 |
52 | 2,3-epoxypropyl | 7 |
53 | atelectatic | 7 |
54 | disease-affected | 7 |
55 | dlsk | 7 |
56 | ethnocultural | 7 |
57 | intra-urban | 7 |
58 | nonceliac | 7 |
59 | bshy-h | 6 |
60 | cdr3 | 6 |
61 | complementarity-determining | 6 |
62 | deamidated | 6 |
63 | ethnoracial | 6 |
64 | hflt | 6 |
65 | inter-segment | 6 |
66 | matrilineal | 6 |
67 | particle-size | 6 |
68 | vd2 | 6 |
69 | whole-organism | 6 |
70 | aloe-treated | 5 |
71 | cagn-3.0t | 5 |
72 | egg-based | 5 |
73 | non-circumferential | 5 |
74 | non-sliding | 5 |
75 | nonchemotherapy | 5 |
76 | rando | 5 |
77 | uim | 5 |
78 | wsd+t | 5 |
79 | cephalopod | 4 |
80 | connatal | 4 |
81 | ethno-religious | 4 |
82 | kemerovo | 4 |
83 | maiden | 4 |
84 | mid-intertidal | 4 |
85 | nearctic | 4 |
86 | no-remodeling | 4 |
87 | perigenital | 4 |
88 | radon-prone | 4 |
89 | riper+ipost | 4 |
90 | sad-depression | 4 |
91 | sulfonamide-trimethoprim | 4 |
92 | un-gi | 4 |
93 | water-extracted | 4 |
94 | within-country | 4 |
95 | -second | 3 |
96 | 10mgq8wk | 3 |
97 | 3-nitro-phenyl | 3 |
98 | antemoro | 3 |
99 | bathymetric | 3 |
100 | day-age | 3 |
101 | diagnostic-related | 3 |
102 | dna-pva-p | 3 |
103 | drugs/drug | 3 |
104 | enterotype | 3 |
105 | extubation-success | 3 |
106 | fa+vb12 | 3 |
107 | glutamine-rich | 3 |
108 | glyde | 3 |
109 | hibmenc | 3 |
110 | hla-ii | 3 |
111 | intra-city | 3 |
112 | ivb-treated | 3 |
113 | kizkalesi | 3 |
114 | levantine | 3 |
115 | lophyl | 3 |
116 | near-wall | 3 |
117 | nicobarese | 3 |
118 | non-acei-treated | 3 |
119 | non-toxaemic | 3 |
120 | pandemic-related | 3 |
121 | phylum-level | 3 |
122 | placebo-hvpc | 3 |
123 | ptx/gjg | 3 |
124 | responder/non-responder | 3 |
125 | rockfish | 3 |
126 | segment-to-segment | 3 |
127 | sex-gender | 3 |
128 | strength-intensity | 3 |
129 | tsallis | 3 |
130 | vegetal/fat | 3 |
131 | wheat-bran | 3 |
132 | 'swine | 2 |
133 | 'unknown | 2 |
134 | -donating | 2 |
135 | -so₂ch₂cooh | 2 |
136 | -unmatched | 2 |
137 | -withdrawing | 2 |
138 | 1.0-mg/kg/day | 2 |
139 | 120alt | 2 |
140 | 129s6 | 2 |
141 | 18s/inter | 2 |
142 | 1996/7 | 2 |
143 | 2,3,6-trimethylphenoxy | 2 |
144 | 25-gy | 2 |
145 | 3-ma-treated | 2 |
146 | 4-injection | 2 |
147 | 5'-hydroxyl | 2 |
148 | abutment/implant | 2 |
149 | agro-climatic | 2 |
150 | aldohexose | 2 |
151 | aminoalkoxy | 2 |
152 | antegastric | 2 |
153 | azt-sys | 2 |
154 | b0/b1 | 2 |
155 | baffin | 2 |
156 | baganda | 2 |
157 | between-position | 2 |
158 | beverly | 2 |
159 | bimusical | 2 |
160 | cancer-suggestive | 2 |
161 | ccb+arb | 2 |
162 | cervicomental | 2 |
163 | cetp-expressing | 2 |
164 | cold-climate | 2 |
165 | crb-age | 2 |
166 | crse2 | 2 |
167 | cv-event | 2 |
168 | dcm-chf | 2 |
169 | difficult-to-see | 2 |
170 | direction-dependent | 2 |
171 | eco-geographical | 2 |
172 | efonidipine-treated | 2 |
173 | energy/food | 2 |
174 | ethyleneoxy | 2 |
175 | evidence-to-practice | 2 |
176 | ewey | 2 |
177 | fbp40 | 2 |
178 | goal-choice | 2 |
179 | hoemophilus | 2 |
180 | hydrate/hydrate | 2 |
181 | i-i-o | 2 |
182 | ibs-mixed | 2 |
183 | ige-related | 2 |
184 | immune-dominant | 2 |
185 | language/country | 2 |
186 | li-a | 2 |
187 | mo-m2,3 | 2 |
188 | moderate-meat-eater | 2 |
189 | non-beta-cell-specific | 2 |
190 | non-ipv | 2 |
191 | non-pmt | 2 |
192 | non-poaf | 2 |
193 | non-sbi | 2 |
194 | non-zinc | 2 |
195 | nonfeedback | 2 |
196 | nonmedicalizing | 2 |
197 | p.o.-treated | 2 |
198 | pamphlet-only | 2 |
199 | phytogeographical | 2 |
200 | piko | 2 |
201 | placebo+oif | 2 |
202 | pn/gpi | 2 |
203 | pricked | 2 |
204 | restricted-fluid | 2 |
205 | rrna/its2 | 2 |
206 | sandhills | 2 |
207 | semitropical | 2 |
208 | seven-letter | 2 |
209 | sex/age | 2 |
210 | standard-solution | 2 |
211 | straightbred | 2 |
212 | sub-nanometre | 2 |
213 | sub-superficial | 2 |
214 | sulfydryl | 2 |
215 | superhydroxide | 2 |
216 | t2wi-positive | 2 |
217 | target-cell | 2 |
218 | tccr-treated | 2 |
219 | teneligliptin-treated | 2 |
220 | third-row | 2 |
221 | tpt-treated | 2 |
222 | trimethoxy | 2 |
223 | triple-bar | 2 |
224 | tsh-deficient | 2 |
225 | two-tea | 2 |
226 | unprepared/mc | 2 |
227 | ute₂ | 2 |
228 | vibrio-challenged | 2 |
229 | δvea | 2 |
230 | π-polarized | 2 |
231 | '-hydroxyl | 1 |
232 | -ch=ch- | 1 |
233 | 0-054 | 1 |
234 | 0.3-ng/ml | 1 |
235 | 0.5y | 1 |
236 | 10-khz | 1 |
237 | 125-iu | 1 |
238 | 15.0-mg | 1 |
239 | 18/12-mg | 1 |
240 | 192-h | 1 |
241 | 2-chloro/cyanobenzyl | 1 |
242 | 2-khz | 1 |
243 | 3',5'-bisphosphorothioate | 1 |
244 | 3'-cs | 1 |
245 | 3-drop | 1 |
246 | 300-mg/d | 1 |
247 | 4kkw | 1 |
248 | 5'-o-levulinoyl | 1 |
249 | 5,6-epoxy | 1 |
250 | 5×5-cm | 1 |
251 | 6-carbethoxy | 1 |
252 | 60,000-iu | 1 |
253 | 600-mg-peramivir | 1 |
254 | 7-hydroxyl | 1 |
255 | 8-to | 1 |
256 | 8.0-mg | 1 |
257 | 80-μg/d | 1 |
258 | aa+lps | 1 |
259 | acidobacterial | 1 |
260 | acratopegal | 1 |
261 | active-sham | 1 |
262 | activity-structure | 1 |
263 | actn3rx | 1 |
264 | adh-deficient | 1 |
265 | aerosol/no | 1 |
266 | age-sex-bmi | 1 |
267 | agroclimatic | 1 |
268 | al-muta'allimin | 1 |
269 | alkoxyl-alkyl | 1 |
270 | alkylperoxy | 1 |
271 | aminopyrrolidine | 1 |
272 | amprolium-treated | 1 |
273 | antero-basal | 1 |
274 | anti-deamidated | 1 |
275 | anti-vegf-treated | 1 |
276 | antigenic/genotypic | 1 |
277 | arb-administered | 1 |
278 | arroscia | 1 |
279 | av6 | 1 |
280 | azelnidipine-treated | 1 |
281 | ba-only | 1 |
282 | bamhiw | 1 |
283 | base-composite | 1 |
284 | bathypelagic | 1 |
285 | bdl-operated | 1 |
286 | berseem-fed | 1 |
287 | betamethasone-alone | 1 |
288 | betamethasone-treated | 1 |
289 | between-pcg | 1 |
290 | bisoprolol-treatment | 1 |
291 | bmvc-only | 1 |
292 | boecop | 1 |
293 | bonner | 1 |
294 | br-treated | 1 |
295 | british-canadian | 1 |
296 | bs-supplemented | 1 |
297 | c-band | 1 |
298 | c-supplemented | 1 |
299 | c3-ss | 1 |
300 | camopi | 1 |
301 | capeiii | 1 |
302 | carboxybiotin | 1 |
303 | care-only | 1 |
304 | carvedilol-treatment | 1 |
305 | cbl-ipi-treated | 1 |
306 | cdb20 | 1 |
307 | cee-mp | 1 |
308 | ceftibuten-fasted | 1 |
309 | census/geographic | 1 |
310 | centro-acinar | 1 |
311 | cervical-facial | 1 |
312 | chamfered | 1 |
313 | chemotypic | 1 |
314 | chlormadinone-treated | 1 |
315 | cholesterol-modulation | 1 |
316 | chx-mwsupra_ir | 1 |
317 | cingulate-brain | 1 |
318 | clevidipine-nicardipine-treated | 1 |
319 | climatically/seasonally | 1 |
320 | clinical-roentgenological | 1 |
321 | clodronate-treated | 1 |
322 | coh+zdy | 1 |
323 | consag | 1 |
324 | contrast-negative | 1 |
325 | conventional-pd-fluid | 1 |
326 | country-of-birth | 1 |
327 | crossed-lamellar | 1 |
328 | cultural/geographic | 1 |
329 | cultural/historical | 1 |
330 | cyclopentenylbenzyl | 1 |
331 | cyto-trophoblast | 1 |
332 | dc-control | 1 |
333 | decathlon/heptathlon | 1 |
334 | decodable | 1 |
335 | deep-middle | 1 |
336 | dengego | 1 |
337 | dentifice | 1 |
338 | deprecated | 1 |
339 | devastative | 1 |
340 | dh-jh-eμ | 1 |
341 | dha+aa-supplemented | 1 |
342 | diet-plus-pravastatin | 1 |
343 | diethylstibestrol | 1 |
344 | diphtheria-tetanus-acellular-pertussis-inactivated | 1 |
345 | dna-calibrated | 1 |
346 | dose-age | 1 |
347 | double-burr-hole | 1 |
348 | dpp+dt | 1 |
349 | duned | 1 |
350 | dvd-training | 1 |
351 | economic-geographical | 1 |
352 | egba | 1 |
353 | eleonora | 1 |
354 | em-treated | 1 |
355 | epidermis/hypodermis | 1 |
356 | epoch-by-epoch | 1 |
357 | esomeprazole-plus-aspirin | 1 |
358 | et-overexpressing | 1 |
359 | exercise-exhausted | 1 |
360 | extravascular/interstitial | 1 |
361 | exxxpg | 1 |
362 | face-cue | 1 |
363 | five-implant | 1 |
364 | flavonoid-treated | 1 |
365 | flisvos | 1 |
366 | floridian | 1 |
367 | fluorouracil-plus-levamisole | 1 |
368 | fortified-diet | 1 |
369 | fpi+hh | 1 |
370 | fronto-tempero-parietal | 1 |
371 | fsh-srf | 1 |
372 | gardened | 1 |
373 | garlic-coated | 1 |
374 | germanic | 1 |
375 | girona | 1 |
376 | gonadotropin-treated | 1 |
377 | gstt1-0 | 1 |
378 | guianese | 1 |
379 | gun5 | 1 |
380 | h+sh | 1 |
381 | ha-7 | 1 |
382 | hay-fever | 1 |
383 | hct-rt | 1 |
384 | hemeroby | 1 |
385 | hib/acellular | 1 |
386 | high-dose-supplemented | 1 |
387 | high-fss | 1 |
388 | high-recurrence-risk | 1 |
389 | high-schizotypy | 1 |
390 | high-sequence | 1 |
391 | high-staining | 1 |
392 | hmb-fa-treated | 1 |
393 | hospital-referral | 1 |
394 | hrp-apr | 1 |
395 | hsv-related | 1 |
396 | hydraulic-fracture | 1 |
397 | hydrochlorothiazide-treated | 1 |
398 | hydroflask-cured | 1 |
399 | hypo-akinetic | 1 |
400 | hypoenhanced | 1 |
401 | hypogastrial | 1 |
402 | hypoxic/nutrient | 1 |
403 | ich-operated | 1 |
404 | igala | 1 |
405 | in-tension | 1 |
406 | income/poverty | 1 |
407 | indazole-3-carboxylates | 1 |
408 | indicational | 1 |
409 | indolinooxazolidine | 1 |
410 | inferior-umbilicus | 1 |
411 | influ-enza | 1 |
412 | influeunza | 1 |
413 | inhibitors+caffeine | 1 |
414 | intact-ovary | 1 |
415 | inter-daily | 1 |
416 | inter-decade | 1 |
417 | intermediate-flavanol | 1 |
418 | interslope | 1 |
419 | intervention-generated | 1 |
420 | intradiurnal | 1 |
421 | intrapathologist | 1 |
422 | inverted-view | 1 |
423 | iodixanol-treated | 1 |
424 | ir/cir | 1 |
425 | irradiation+neurotensin | 1 |
426 | knowlege | 1 |
427 | krajina | 1 |
428 | krg+3-np | 1 |
429 | kwt | 1 |
430 | laplacian-based | 1 |
431 | late-refill | 1 |
432 | ld-qiv-as | 1 |
433 | ld-tiv-as | 1 |
434 | leptospiral-vaccinated | 1 |
435 | levulinoyl | 1 |
436 | ligand/cxcr3 | 1 |
437 | loop/linker | 1 |
438 | low-as-ea | 1 |
439 | low-middle-risk | 1 |
440 | low-treatment | 1 |
441 | low-wmc | 1 |
442 | mailed-materials | 1 |
443 | mainstreamed-only | 1 |
444 | mec=cme2 | 1 |
445 | medium-ca | 1 |
446 | medium-exposure | 1 |
447 | medium-titre | 1 |
448 | melatonin+amitriptyline | 1 |
449 | menyanthoideae | 1 |
450 | metoprolol+iso | 1 |
451 | mfse400 | 1 |
452 | microanatomical | 1 |
453 | microhemorragic | 1 |
454 | mid-socioeconomic | 1 |
455 | mixed-case | 1 |
456 | mmp-13-2024 | 1 |
457 | mo-l2,3 | 1 |
458 | molopo | 1 |
459 | morphine-naltrexane | 1 |
460 | mta/cem | 1 |
461 | mtx+pbo | 1 |
462 | mtx/res-treated | 1 |
463 | multidecade | 1 |
464 | mumijo-administered | 1 |
465 | n-tol-p | 1 |
466 | nasopharyngeal+oropharyngeal | 1 |
467 | nebl-treated | 1 |
468 | needling-sensation | 1 |
469 | ni₂₇₀₀ | 1 |
470 | no-bci | 1 |
471 | no-clopidogrel | 1 |
472 | no-fever | 1 |
473 | no-iron | 1 |
474 | no-qlt | 1 |
475 | no-rupture | 1 |
476 | no-sege | 1 |
477 | no-suction | 1 |
478 | no-titration | 1 |
479 | no-traction | 1 |
480 | no-z-buf | 1 |
481 | non-adrenalectomy | 1 |
482 | non-altitude | 1 |
483 | non-appendicular | 1 |
484 | non-ayurvedic | 1 |
485 | non-bather | 1 |
486 | non-caregiving | 1 |
487 | non-diet/non-exercise | 1 |
488 | non-enema | 1 |
489 | non-epidemiologically | 1 |
490 | non-futi | 1 |
491 | non-hh | 1 |
492 | non-hyperkalemic | 1 |
493 | non-incentive | 1 |
494 | non-infarct-containing | 1 |
495 | non-irsm | 1 |
496 | non-niv | 1 |
497 | non-qv | 1 |
498 | non-ranitidine | 1 |
499 | non-restenotic | 1 |
500 | non-selenium-supplemented | 1 |
501 | non-thermocycled | 1 |
502 | non-transfection | 1 |
503 | non-transfusion | 1 |
504 | nonanthracotic | 1 |
505 | nonexpansion | 1 |
506 | nonhaptics-training | 1 |
507 | nonlased | 1 |
508 | nonprototype | 1 |
509 | nonreoperation | 1 |
510 | nonstricture | 1 |
511 | nontrophoblast | 1 |
512 | noradrenalin-deficient | 1 |
513 | normal-proestrus | 1 |
514 | normoresponder | 1 |
515 | northern/southern/eastern/western | 1 |
516 | noseless | 1 |
517 | nro | 1 |
518 | nsaid-assigned | 1 |
519 | ntlp | 1 |
520 | od+lp | 1 |
521 | once-remote | 1 |
522 | outcomes-all | 1 |
523 | oxygen-inhalation | 1 |
524 | p-o-p | 1 |
525 | para-mesangial | 1 |
526 | para-nitro | 1 |
527 | passive-stretching | 1 |
528 | pcw-bx | 1 |
529 | pentecostal-charismatic | 1 |
530 | perivascluar | 1 |
531 | physician-management | 1 |
532 | pianist | 1 |
533 | pitjantjatjara | 1 |
534 | pomegranate-treated | 1 |
535 | poor-lsd-compliance | 1 |
536 | poor-planning | 1 |
537 | pore-size | 1 |
538 | post-acas | 1 |
539 | post-cst | 1 |
540 | post-toddler | 1 |
541 | postadvisory | 1 |
542 | posterior-parietal-frontal | 1 |
543 | pre-fed | 1 |
544 | pre-specificed | 1 |
545 | prednisone-alone | 1 |
546 | pregabalin/placebo | 1 |
547 | prk+mmc | 1 |
548 | propylenedioxy | 1 |
549 | protein-deficit | 1 |
550 | psychopathic-like | 1 |
551 | quasiprobability | 1 |
552 | race/gender | 1 |
553 | rebel-controlled | 1 |
554 | reductive/nucleophilic | 1 |
555 | ree-treated | 1 |
556 | removal-technique | 1 |
557 | rgch-supplemented | 1 |
558 | risk-aversion-gain | 1 |
559 | rorγt-overexpression | 1 |
560 | rosiglitazone-supplemented | 1 |
561 | rostov | 1 |
562 | ruminant-derived | 1 |
563 | rural/non-rural | 1 |
564 | salian | 1 |
565 | scrc-mucinous | 1 |
566 | scytonemin-poor | 1 |
567 | separate-vaccine | 1 |
568 | sevoflurane-treated | 1 |
569 | sex-by-race | 1 |
570 | sham-vertebroplasty | 1 |
571 | short-proestrus | 1 |
572 | shoulder/thoracic | 1 |
573 | sirna-control | 1 |
574 | sirolimus-only | 1 |
575 | sjhst-only | 1 |
576 | soche | 1 |
577 | social-ethnic | 1 |
578 | sociobiologic | 1 |
579 | southeast-asian | 1 |
580 | starting-age | 1 |
581 | statin-unexposed | 1 |
582 | stem-negative | 1 |
583 | sth-endemic | 1 |
584 | styrenyl | 1 |
585 | sulfate/sulfonate | 1 |
586 | surface-reactive | 1 |
587 | surgeon-level | 1 |
588 | tam-plus-chemotherapy | 1 |
589 | tbo/light | 1 |
590 | tcralphabeta | 1 |
591 | tc® | 1 |
592 | teas+ga | 1 |
593 | temporo-cerebellum | 1 |
594 | tented-leaflet | 1 |
595 | tetanus/diphtheria/acellular | 1 |
596 | th-2-mediated | 1 |
597 | thio-phen-2-yl-methyl-amino-n-propyl | 1 |
598 | three-transit | 1 |
599 | thswd-treated | 1 |
600 | thyroglobulin-beta-d-galactosidase | 1 |
601 | tobramycin-treatment | 1 |
602 | two-cage | 1 |
603 | tzl-treated | 1 |
604 | udca+bf | 1 |
605 | upward-pointing | 1 |
606 | urban-regional | 1 |
607 | us8 | 1 |
608 | uzbec | 1 |
609 | vaccine-wildtype | 1 |
610 | vam-treated | 1 |
611 | vasculature/csf | 1 |
612 | visual-association | 1 |
613 | vsv/hcv | 1 |
614 | wealth-based | 1 |
615 | web-training | 1 |
616 | within-day/between-days | 1 |
617 | worms-scored | 1 |
618 | wortmannin+caffeine | 1 |
619 | zn-exposed | 1 |
620 | zn-only | 1 |
1 | '-hydroxyl | 1 |
2 | 'swine | 2 |
3 | 'unknown | 2 |
4 | -ch=ch- | 1 |
5 | -donating | 2 |
6 | -second | 3 |
7 | -so₂ch₂cooh | 2 |
8 | -unmatched | 2 |
9 | -withdrawing | 2 |
10 | 0-054 | 1 |
11 | 0.3-ng/ml | 1 |
12 | 0.5y | 1 |
13 | 1.0-mg/kg/day | 2 |
14 | 10-khz | 1 |
15 | 10mgq8wk | 3 |
16 | 120alt | 2 |
17 | 125-iu | 1 |
18 | 129s6 | 2 |
19 | 15.0-mg | 1 |
20 | 18/12-mg | 1 |
21 | 18s/inter | 2 |
22 | 192-h | 1 |
23 | 1996/7 | 2 |
24 | 2,3,6-trimethylphenoxy | 2 |
25 | 2,3-epoxypropyl | 7 |
26 | 2-chloro/cyanobenzyl | 1 |
27 | 2-khz | 1 |
28 | 25-gy | 2 |
29 | 3',5'-bisphosphorothioate | 1 |
30 | 3'-cs | 1 |
31 | 3'-untranslated | 95 |
32 | 3-drop | 1 |
33 | 3-ma-treated | 2 |
34 | 3-nitro-phenyl | 3 |
35 | 300-mg/d | 1 |
36 | 4-injection | 2 |
37 | 4kkw | 1 |
38 | 5'-hydroxyl | 2 |
39 | 5'-o-levulinoyl | 1 |
40 | 5'-untranslated | 30 |
41 | 5,6-epoxy | 1 |
42 | 5×5-cm | 1 |
43 | 6-carbethoxy | 1 |
44 | 60,000-iu | 1 |
45 | 600-mg-peramivir | 1 |
46 | 7-hydroxyl | 1 |
47 | 8-to | 1 |
48 | 8.0-mg | 1 |
49 | 80-μg/d | 1 |
50 | aa+lps | 1 |
51 | abutment/implant | 2 |
52 | acidobacterial | 1 |
53 | acratopegal | 1 |
54 | active-sham | 1 |
55 | activity-structure | 1 |
56 | actn3rx | 1 |
57 | adh-deficient | 1 |
58 | aerosol/no | 1 |
59 | age-gender | 13 |
60 | age-sex | 30 |
61 | age-sex-bmi | 1 |
62 | age/sex | 12 |
63 | agro-climatic | 2 |
64 | agroclimatic | 1 |
65 | al-muta'allimin | 1 |
66 | aldohexose | 2 |
67 | alkoxyl-alkyl | 1 |
68 | alkylperoxy | 1 |
69 | aloe-treated | 5 |
70 | aminoalkoxy | 2 |
71 | aminopyrrolidine | 1 |
72 | amprolium-treated | 1 |
73 | antegastric | 2 |
74 | antemoro | 3 |
75 | antero-basal | 1 |
76 | anti-deamidated | 1 |
77 | anti-vegf-treated | 1 |
78 | antibody-drug | 20 |
79 | antigenic/genotypic | 1 |
80 | arb-administered | 1 |
81 | arroscia | 1 |
82 | atelectatic | 7 |
83 | av6 | 1 |
84 | avian | 474 |
85 | azelnidipine-treated | 1 |
86 | azt-sys | 2 |
87 | b0/b1 | 2 |
88 | ba-only | 1 |
89 | baffin | 2 |
90 | baganda | 2 |
91 | bamhiw | 1 |
92 | base-composite | 1 |
93 | bathymetric | 3 |
94 | bathypelagic | 1 |
95 | bdl-operated | 1 |
96 | berseem-fed | 1 |
97 | betamethasone-alone | 1 |
98 | betamethasone-treated | 1 |
99 | between-pcg | 1 |
100 | between-position | 2 |
101 | beverly | 2 |
102 | bimusical | 2 |
103 | biogeographic | 18 |
104 | bisoprolol-treatment | 1 |
105 | bmvc-only | 1 |
106 | boecop | 1 |
107 | bonner | 1 |
108 | br-treated | 1 |
109 | british-canadian | 1 |
110 | bs-supplemented | 1 |
111 | bshy-h | 6 |
112 | c-band | 1 |
113 | c-supplemented | 1 |
114 | c3-ss | 1 |
115 | cagn-3.0t | 5 |
116 | camopi | 1 |
117 | cancer-suggestive | 2 |
118 | capeiii | 1 |
119 | carboxybiotin | 1 |
120 | care-only | 1 |
121 | carvedilol-treatment | 1 |
122 | cbl-ipi-treated | 1 |
123 | ccb+arb | 2 |
124 | cdb20 | 1 |
125 | cdr3 | 6 |
126 | cee-mp | 1 |
127 | ceftibuten-fasted | 1 |
128 | census/geographic | 1 |
129 | centro-acinar | 1 |
130 | cephalopod | 4 |
131 | cervical-facial | 1 |
132 | cervicomental | 2 |
133 | cetp-expressing | 2 |
134 | chamfered | 1 |
135 | chemotypic | 1 |
136 | chlormadinone-treated | 1 |
137 | cholesterol-modulation | 1 |
138 | chx-mwsupra_ir | 1 |
139 | cingulate-brain | 1 |
140 | clevidipine-nicardipine-treated | 1 |
141 | climatically/seasonally | 1 |
142 | clinical-roentgenological | 1 |
143 | clodronate-treated | 1 |
144 | coh+zdy | 1 |
145 | cold-climate | 2 |
146 | complementarity-determining | 6 |
147 | connatal | 4 |
148 | consag | 1 |
149 | contrast-negative | 1 |
150 | conventional-pd-fluid | 1 |
151 | country-of-birth | 1 |
152 | crb-age | 2 |
153 | crenarchaeotal | 8 |
154 | crossed-lamellar | 1 |
155 | crse2 | 2 |
156 | cultural/geographic | 1 |
157 | cultural/historical | 1 |
158 | cv-event | 2 |
159 | cyclopentenylbenzyl | 1 |
160 | cyto-trophoblast | 1 |
161 | day-age | 3 |
162 | dc-control | 1 |
163 | dcm-chf | 2 |
164 | deamidated | 6 |
165 | decathlon/heptathlon | 1 |
166 | decodable | 1 |
167 | deep-middle | 1 |
168 | dengego | 1 |
169 | dentifice | 1 |
170 | deprecated | 1 |
171 | devastative | 1 |
172 | dh-jh-eμ | 1 |
173 | dha+aa-supplemented | 1 |
174 | diagnostic-related | 3 |
175 | diet-plus-pravastatin | 1 |
176 | diethylstibestrol | 1 |
177 | difficult-to-see | 2 |
178 | diphtheria-tetanus-acellular-pertussis-inactivated | 1 |
179 | direction-dependent | 2 |
180 | disease-affected | 7 |
181 | dlsk | 7 |
182 | dna-calibrated | 1 |
183 | dna-pva-p | 3 |
184 | dose-age | 1 |
185 | double-burr-hole | 1 |
186 | dpp+dt | 1 |
187 | drugs/drug | 3 |
188 | duned | 1 |
189 | dvd-training | 1 |
190 | eco-geographical | 2 |
191 | economic-geographical | 1 |
192 | efonidipine-treated | 2 |
193 | egba | 1 |
194 | egg-based | 5 |
195 | electron-donating | 30 |
196 | electron-withdrawing | 59 |
197 | eleonora | 1 |
198 | em-treated | 1 |
199 | energy/food | 2 |
200 | enterotype | 3 |
201 | epidermis/hypodermis | 1 |
202 | epoch-by-epoch | 1 |
203 | esomeprazole-plus-aspirin | 1 |
204 | et-overexpressing | 1 |
205 | ethnic | 1,903 |
206 | ethnic-based | 8 |
207 | ethnic/racial | 21 |
208 | ethnical | 9 |
209 | ethno-religious | 4 |
210 | ethnocultural | 7 |
211 | ethnoracial | 6 |
212 | ethyleneoxy | 2 |
213 | evidence-practice | 13 |
214 | evidence-to-practice | 2 |
215 | ewey | 2 |
216 | exercise-exhausted | 1 |
217 | extravascular/interstitial | 1 |
218 | extubation-success | 3 |
219 | exxxpg | 1 |
220 | fa+vb12 | 3 |
221 | face-cue | 1 |
222 | fbp40 | 2 |
223 | five-implant | 1 |
224 | flavonoid-treated | 1 |
225 | flisvos | 1 |
226 | floridian | 1 |
227 | floristic | 11 |
228 | fluorouracil-plus-levamisole | 1 |
229 | fortified-diet | 1 |
230 | fpi+hh | 1 |
231 | fronto-tempero-parietal | 1 |
232 | fsh-srf | 1 |
233 | gardened | 1 |
234 | garlic-coated | 1 |
235 | geographic | 1,010 |
236 | geographical | 815 |
237 | germanic | 1 |
238 | girona | 1 |
239 | glutamine-rich | 3 |
240 | glyde | 3 |
241 | goal-choice | 2 |
242 | gonadotropin-treated | 1 |
243 | group-related | 12 |
244 | gstt1-0 | 1 |
245 | guianese | 1 |
246 | gun5 | 1 |
247 | h+sh | 1 |
248 | ha-7 | 1 |
249 | hay-fever | 1 |
250 | hct-rt | 1 |
251 | hemeroby | 1 |
252 | hflt | 6 |
253 | hib/acellular | 1 |
254 | hibmenc | 3 |
255 | high-dose-supplemented | 1 |
256 | high-fss | 1 |
257 | high-recurrence-risk | 1 |
258 | high-schizotypy | 1 |
259 | high-sequence | 1 |
260 | high-staining | 1 |
261 | hiv-status | 8 |
262 | hla-ii | 3 |
263 | hmb-fa-treated | 1 |
264 | hoemophilus | 2 |
265 | hospital-referral | 1 |
266 | hrp-apr | 1 |
267 | hsv-related | 1 |
268 | hydrate/hydrate | 2 |
269 | hydraulic-fracture | 1 |
270 | hydrochlorothiazide-treated | 1 |
271 | hydroflask-cured | 1 |
272 | hydroxyl | 453 |
273 | hypo-akinetic | 1 |
274 | hypoenhanced | 1 |
275 | hypogastrial | 1 |
276 | hypoxic/nutrient | 1 |
277 | i-i-o | 2 |
278 | ibs-mixed | 2 |
279 | ich-operated | 1 |
280 | igala | 1 |
281 | ige-related | 2 |
282 | immune-dominant | 2 |
283 | in-tension | 1 |
284 | income/poverty | 1 |
285 | indazole-3-carboxylates | 1 |
286 | indicational | 1 |
287 | indolinooxazolidine | 1 |
288 | inferior-umbilicus | 1 |
289 | influ-enza | 1 |
290 | influeunza | 1 |
291 | inhibitors+caffeine | 1 |
292 | intact-ovary | 1 |
293 | inter-daily | 1 |
294 | inter-decade | 1 |
295 | inter-segment | 6 |
296 | intermediate-flavanol | 1 |
297 | interslope | 1 |
298 | interspecific | 59 |
299 | intervention-generated | 1 |
300 | intra-city | 3 |
301 | intra-urban | 7 |
302 | intradiurnal | 1 |
303 | intrapathologist | 1 |
304 | intraspecific | 52 |
305 | inverted-view | 1 |
306 | iodixanol-treated | 1 |
307 | ir/cir | 1 |
308 | irradiation+neurotensin | 1 |
309 | ivb-treated | 3 |
310 | kemerovo | 4 |
311 | kizkalesi | 3 |
312 | knowlege | 1 |
313 | krajina | 1 |
314 | krg+3-np | 1 |
315 | kwt | 1 |
316 | language/country | 2 |
317 | laplacian-based | 1 |
318 | lased | 10 |
319 | late-refill | 1 |
320 | latitudinal | 39 |
321 | ld-qiv-as | 1 |
322 | ld-tiv-as | 1 |
323 | leptospiral-vaccinated | 1 |
324 | levantine | 3 |
325 | levulinoyl | 1 |
326 | li-a | 2 |
327 | ligand/cxcr3 | 1 |
328 | livedo | 14 |
329 | loop/linker | 1 |
330 | lophyl | 3 |
331 | low-as-ea | 1 |
332 | low-middle-risk | 1 |
333 | low-probability | 8 |
334 | low-treatment | 1 |
335 | low-wmc | 1 |
336 | maiden | 4 |
337 | mailed-materials | 1 |
338 | mainstreamed-only | 1 |
339 | matrilineal | 6 |
340 | mec=cme2 | 1 |
341 | medium-ca | 1 |
342 | medium-exposure | 1 |
343 | medium-titre | 1 |
344 | melatonin+amitriptyline | 1 |
345 | menyanthoideae | 1 |
346 | meth-oxy | 12 |
347 | methoxyl | 15 |
348 | metoprolol+iso | 1 |
349 | mfse400 | 1 |
350 | microanatomical | 1 |
351 | microhemorragic | 1 |
352 | mid-intertidal | 4 |
353 | mid-socioeconomic | 1 |
354 | mixed-case | 1 |
355 | mmp-13-2024 | 1 |
356 | mo-l2,3 | 1 |
357 | mo-m2,3 | 2 |
358 | moderate-meat-eater | 2 |
359 | molopo | 1 |
360 | monocotyledonous | 8 |
361 | morphine-naltrexane | 1 |
362 | mta/cem | 1 |
363 | mtx+pbo | 1 |
364 | mtx/res-treated | 1 |
365 | multidecade | 1 |
366 | mumijo-administered | 1 |
367 | n-tol-p | 1 |
368 | nasopharyngeal+oropharyngeal | 1 |
369 | near-wall | 3 |
370 | nearctic | 4 |
371 | nebl-treated | 1 |
372 | needling-sensation | 1 |
373 | nicobar | 14 |
374 | nicobarese | 3 |
375 | ni₂₇₀₀ | 1 |
376 | no-bci | 1 |
377 | no-clopidogrel | 1 |
378 | no-fever | 1 |
379 | no-iron | 1 |
380 | no-qlt | 1 |
381 | no-remodeling | 4 |
382 | no-rupture | 1 |
383 | no-sege | 1 |
384 | no-suction | 1 |
385 | no-titration | 1 |
386 | no-traction | 1 |
387 | no-z-buf | 1 |
388 | non-acei-treated | 3 |
389 | non-adrenalectomy | 1 |
390 | non-altitude | 1 |
391 | non-appendicular | 1 |
392 | non-ayurvedic | 1 |
393 | non-bather | 1 |
394 | non-beta-cell-specific | 2 |
395 | non-caregiving | 1 |
396 | non-circumferential | 5 |
397 | non-diet/non-exercise | 1 |
398 | non-enema | 1 |
399 | non-epidemiologically | 1 |
400 | non-futi | 1 |
401 | non-hh | 1 |
402 | non-hyperkalemic | 1 |
403 | non-incentive | 1 |
404 | non-infarct-containing | 1 |
405 | non-ipv | 2 |
406 | non-irsm | 1 |
407 | non-niv | 1 |
408 | non-pmt | 2 |
409 | non-poaf | 2 |
410 | non-qv | 1 |
411 | non-ranitidine | 1 |
412 | non-restenotic | 1 |
413 | non-sbi | 2 |
414 | non-selenium-supplemented | 1 |
415 | non-sleep | 11 |
416 | non-sliding | 5 |
417 | non-thermocycled | 1 |
418 | non-toxaemic | 3 |
419 | non-transfection | 1 |
420 | non-transfusion | 1 |
421 | non-zinc | 2 |
422 | nonanthracotic | 1 |
423 | nonceliac | 7 |
424 | nonchemotherapy | 5 |
425 | nonexpansion | 1 |
426 | nonfeedback | 2 |
427 | nonhaptics-training | 1 |
428 | nonlased | 1 |
429 | nonmedicalizing | 2 |
430 | nonprototype | 1 |
431 | nonreoperation | 1 |
432 | nonstricture | 1 |
433 | nontrophoblast | 1 |
434 | noradrenalin-deficient | 1 |
435 | normal-proestrus | 1 |
436 | normoresponder | 1 |
437 | northern/southern/eastern/western | 1 |
438 | noseless | 1 |
439 | nro | 1 |
440 | nsaid-assigned | 1 |
441 | ntlp | 1 |
442 | od+lp | 1 |
443 | once-remote | 1 |
444 | outcomes-all | 1 |
445 | oxygen-containing | 17 |
446 | oxygen-free | 16 |
447 | oxygen-inhalation | 1 |
448 | p-o-p | 1 |
449 | p.o.-treated | 2 |
450 | pamphlet-only | 2 |
451 | pandemic-related | 3 |
452 | para-mesangial | 1 |
453 | para-nitro | 1 |
454 | particle-size | 6 |
455 | passive-stretching | 1 |
456 | pcw-bx | 1 |
457 | pentecostal-charismatic | 1 |
458 | perigenital | 4 |
459 | perivascluar | 1 |
460 | phylum-level | 3 |
461 | physician-management | 1 |
462 | phytogeographical | 2 |
463 | pianist | 1 |
464 | piko | 2 |
465 | pitjantjatjara | 1 |
466 | placebo+oif | 2 |
467 | placebo-hvpc | 3 |
468 | pn/gpi | 2 |
469 | pomegranate-treated | 1 |
470 | poor-lsd-compliance | 1 |
471 | poor-planning | 1 |
472 | pore-size | 1 |
473 | post-acas | 1 |
474 | post-cst | 1 |
475 | post-toddler | 1 |
476 | postadvisory | 1 |
477 | posterior-parietal-frontal | 1 |
478 | pre-fed | 1 |
479 | pre-specificed | 1 |
480 | prednisone-alone | 1 |
481 | pregabalin/placebo | 1 |
482 | pricked | 2 |
483 | prk+mmc | 1 |
484 | propylenedioxy | 1 |
485 | protein-deficit | 1 |
486 | psychopathic-like | 1 |
487 | ptx/gjg | 3 |
488 | quasiprobability | 1 |
489 | race-ethnic | 9 |
490 | race-sex | 8 |
491 | race/ethnic | 43 |
492 | race/gender | 1 |
493 | racial | 786 |
494 | racial-ethnic | 30 |
495 | racial/ethnic | 341 |
496 | radon-prone | 4 |
497 | rando | 5 |
498 | rebel-controlled | 1 |
499 | reductive/nucleophilic | 1 |
500 | ree-treated | 1 |
501 | removal-technique | 1 |
502 | responder/non-responder | 3 |
503 | restricted-fluid | 2 |
504 | rgch-supplemented | 1 |
505 | riper+ipost | 4 |
506 | risk-aversion-gain | 1 |
507 | rockfish | 3 |
508 | rorγt-overexpression | 1 |
509 | rosiglitazone-supplemented | 1 |
510 | rostov | 1 |
511 | rrna/its2 | 2 |
512 | ruminant-derived | 1 |
513 | rural-urban | 17 |
514 | rural/non-rural | 1 |
515 | sad-depression | 4 |
516 | salian | 1 |
517 | sandhills | 2 |
518 | scrc-mucinous | 1 |
519 | scytonemin-poor | 1 |
520 | seasonal | 1,479 |
521 | segment-to-segment | 3 |
522 | semitropical | 2 |
523 | separate-vaccine | 1 |
524 | seven-letter | 2 |
525 | sevoflurane-treated | 1 |
526 | sex-by-race | 1 |
527 | sex-gender | 3 |
528 | sex/age | 2 |
529 | sham-vertebroplasty | 1 |
530 | short-proestrus | 1 |
531 | shoulder/thoracic | 1 |
532 | sirna-control | 1 |
533 | sirolimus-only | 1 |
534 | sjhst-only | 1 |
535 | soche | 1 |
536 | social-ethnic | 1 |
537 | sociobiologic | 1 |
538 | southeast-asian | 1 |
539 | standard-solution | 2 |
540 | starting-age | 1 |
541 | statin-unexposed | 1 |
542 | stem-negative | 1 |
543 | sth-endemic | 1 |
544 | straightbred | 2 |
545 | strength-intensity | 3 |
546 | styrenyl | 1 |
547 | sub-nanometre | 2 |
548 | sub-superficial | 2 |
549 | sulfate/sulfonate | 1 |
550 | sulfonamide-trimethoprim | 4 |
551 | sulfydryl | 2 |
552 | superhydroxide | 2 |
553 | superordinate | 19 |
554 | surface-reactive | 1 |
555 | surgeon-level | 1 |
556 | t2wi-positive | 2 |
557 | tam-plus-chemotherapy | 1 |
558 | target-cell | 2 |
559 | taxonomic | 247 |
560 | tbo/light | 1 |
561 | tccr-treated | 2 |
562 | tcralphabeta | 1 |
563 | tc® | 1 |
564 | teas+ga | 1 |
565 | temporo-cerebellum | 1 |
566 | teneligliptin-treated | 2 |
567 | tented-leaflet | 1 |
568 | tetanus/diphtheria/acellular | 1 |
569 | th-2-mediated | 1 |
570 | thio-phen-2-yl-methyl-amino-n-propyl | 1 |
571 | third-row | 2 |
572 | three-transit | 1 |
573 | thswd-treated | 1 |
574 | thyroglobulin-beta-d-galactosidase | 1 |
575 | tobramycin-treatment | 1 |
576 | toxin-treated | 8 |
577 | tpt-treated | 2 |
578 | transatlantic | 32 |
579 | trimethoxy | 2 |
580 | triple-bar | 2 |
581 | tsallis | 3 |
582 | tsh-deficient | 2 |
583 | two-cage | 1 |
584 | two-tea | 2 |
585 | tyrosyl | 13 |
586 | tzl-treated | 1 |
587 | udca+bf | 1 |
588 | uim | 5 |
589 | un-gi | 4 |
590 | unprepared/mc | 2 |
591 | upward-pointing | 1 |
592 | urban-regional | 1 |
593 | us8 | 1 |
594 | ute₂ | 2 |
595 | uzbec | 1 |
596 | vaccine-wildtype | 1 |
597 | valent | 16 |
598 | vam-treated | 1 |
599 | varietal | 9 |
600 | vasculature/csf | 1 |
601 | vd2 | 6 |
602 | vegetal/fat | 3 |
603 | vibrio-challenged | 2 |
604 | visual-association | 1 |
605 | vsv/hcv | 1 |
606 | water-extracted | 4 |
607 | wealth-based | 1 |
608 | web-training | 1 |
609 | wheat-bran | 3 |
610 | whole-organism | 6 |
611 | within-country | 4 |
612 | within-day/between-days | 1 |
613 | worms-scored | 1 |
614 | wortmannin+caffeine | 1 |
615 | wsd+t | 5 |
616 | yangming | 15 |
617 | zn-exposed | 1 |
618 | zn-only | 1 |
619 | δvea | 2 |
620 | π-polarized | 2 |
1 | -ch=ch- | 1 |
2 | gstt1-0 | 1 |
3 | mfse400 | 1 |
4 | cdb20 | 1 |
5 | fbp40 | 2 |
6 | b0/b1 | 2 |
7 | fa+vb12 | 3 |
8 | vd2 | 6 |
9 | mec=cme2 | 1 |
10 | crse2 | 2 |
11 | rrna/its2 | 2 |
12 | mo-l2,3 | 1 |
13 | mo-m2,3 | 2 |
14 | ligand/cxcr3 | 1 |
15 | cdr3 | 6 |
16 | mmp-13-2024 | 1 |
17 | 0-054 | 1 |
18 | gun5 | 1 |
19 | 129s6 | 2 |
20 | av6 | 1 |
21 | ha-7 | 1 |
22 | 1996/7 | 2 |
23 | us8 | 1 |
24 | li-a | 2 |
25 | egba | 1 |
26 | medium-ca | 1 |
27 | baganda | 2 |
28 | low-as-ea | 1 |
29 | two-tea | 2 |
30 | δvea | 2 |
31 | teas+ga | 1 |
32 | arroscia | 1 |
33 | igala | 1 |
34 | non-enema | 1 |
35 | krajina | 1 |
36 | girona | 1 |
37 | pitjantjatjara | 1 |
38 | eleonora | 1 |
39 | tcralphabeta | 1 |
40 | influ-enza | 1 |
41 | influeunza | 1 |
42 | ccb+arb | 2 |
43 | nonceliac | 7 |
44 | uzbec | 1 |
45 | shoulder/thoracic | 1 |
46 | non-ayurvedic | 1 |
47 | non-beta-cell-specific | 2 |
48 | intraspecific | 52 |
49 | interspecific | 59 |
50 | bathypelagic | 1 |
51 | microhemorragic | 1 |
52 | sociobiologic | 1 |
53 | geographic | 1,010 |
54 | cultural/geographic | 1 |
55 | census/geographic | 1 |
56 | biogeographic | 18 |
57 | reductive/nucleophilic | 1 |
58 | non-toxaemic | 3 |
59 | sth-endemic | 1 |
60 | non-hyperkalemic | 1 |
61 | mid-socioeconomic | 1 |
62 | taxonomic | 247 |
63 | germanic | 1 |
64 | ethnic | 1,903 |
65 | race-ethnic | 9 |
66 | racial-ethnic | 30 |
67 | social-ethnic | 1 |
68 | race/ethnic | 43 |
69 | racial/ethnic | 341 |
70 | chemotypic | 1 |
71 | antigenic/genotypic | 1 |
72 | bathymetric | 3 |
73 | antegastric | 2 |
74 | agro-climatic | 2 |
75 | agroclimatic | 1 |
76 | pentecostal-charismatic | 1 |
77 | atelectatic | 7 |
78 | nearctic | 4 |
79 | hypo-akinetic | 1 |
80 | transatlantic | 32 |
81 | nonanthracotic | 1 |
82 | non-restenotic | 1 |
83 | floristic | 11 |
84 | unprepared/mc | 2 |
85 | prk+mmc | 1 |
86 | low-wmc | 1 |
87 | hibmenc | 3 |
88 | non-zinc | 2 |
89 | placebo-hvpc | 3 |
90 | 300-mg/d | 1 |
91 | 80-μg/d | 1 |
92 | pre-specificed | 1 |
93 | hypoenhanced | 1 |
94 | pre-fed | 1 |
95 | berseem-fed | 1 |
96 | vibrio-challenged | 2 |
97 | -unmatched | 2 |
98 | pricked | 2 |
99 | non-thermocycled | 1 |
100 | rebel-controlled | 1 |
101 | gardened | 1 |
102 | nsaid-assigned | 1 |
103 | duned | 1 |
104 | straightbred | 2 |
105 | chamfered | 1 |
106 | arb-administered | 1 |
107 | mumijo-administered | 1 |
108 | worms-scored | 1 |
109 | hydroflask-cured | 1 |
110 | ethnic-based | 8 |
111 | egg-based | 5 |
112 | wealth-based | 1 |
113 | laplacian-based | 1 |
114 | lased | 10 |
115 | nonlased | 1 |
116 | zn-exposed | 1 |
117 | statin-unexposed | 1 |
118 | deprecated | 1 |
119 | deamidated | 6 |
120 | anti-deamidated | 1 |
121 | p.o.-treated | 2 |
122 | hmb-fa-treated | 1 |
123 | 3-ma-treated | 2 |
124 | ivb-treated | 3 |
125 | flavonoid-treated | 1 |
126 | thswd-treated | 1 |
127 | hydrochlorothiazide-treated | 1 |
128 | ree-treated | 1 |
129 | sevoflurane-treated | 1 |
130 | azelnidipine-treated | 1 |
131 | efonidipine-treated | 2 |
132 | clevidipine-nicardipine-treated | 1 |
133 | chlormadinone-treated | 1 |
134 | betamethasone-treated | 1 |
135 | aloe-treated | 5 |
136 | pomegranate-treated | 1 |
137 | clodronate-treated | 1 |
138 | anti-vegf-treated | 1 |
139 | non-acei-treated | 3 |
140 | cbl-ipi-treated | 1 |
141 | nebl-treated | 1 |
142 | iodixanol-treated | 1 |
143 | tzl-treated | 1 |
144 | vam-treated | 1 |
145 | em-treated | 1 |
146 | amprolium-treated | 1 |
147 | gonadotropin-treated | 1 |
148 | teneligliptin-treated | 2 |
149 | toxin-treated | 8 |
150 | br-treated | 1 |
151 | tccr-treated | 2 |
152 | mtx/res-treated | 1 |
153 | tpt-treated | 2 |
154 | th-2-mediated | 1 |
155 | pandemic-related | 3 |
156 | diagnostic-related | 3 |
157 | ige-related | 2 |
158 | group-related | 12 |
159 | hsv-related | 1 |
160 | 3'-untranslated | 95 |
161 | 5'-untranslated | 30 |
162 | leptospiral-vaccinated | 1 |
163 | garlic-coated | 1 |
164 | dna-calibrated | 1 |
165 | intervention-generated | 1 |
166 | ich-operated | 1 |
167 | bdl-operated | 1 |
168 | diphtheria-tetanus-acellular-pertussis-inactivated | 1 |
169 | water-extracted | 4 |
170 | disease-affected | 7 |
171 | dha+aa-supplemented | 1 |
172 | c-supplemented | 1 |
173 | rosiglitazone-supplemented | 1 |
174 | high-dose-supplemented | 1 |
175 | rgch-supplemented | 1 |
176 | non-selenium-supplemented | 1 |
177 | bs-supplemented | 1 |
178 | ceftibuten-fasted | 1 |
179 | exercise-exhausted | 1 |
180 | ruminant-derived | 1 |
181 | ibs-mixed | 2 |
182 | π-polarized | 2 |
183 | restricted-fluid | 2 |
184 | conventional-pd-fluid | 1 |
185 | c-band | 1 |
186 | -second | 3 |
187 | energy/food | 2 |
188 | cephalopod | 4 |
189 | menyanthoideae | 1 |
190 | sex-by-race | 1 |
191 | dentifice | 1 |
192 | goal-choice | 2 |
193 | evidence-practice | 13 |
194 | evidence-to-practice | 2 |
195 | poor-lsd-compliance | 1 |
196 | high-sequence | 1 |
197 | inter-decade | 1 |
198 | multidecade | 1 |
199 | superhydroxide | 2 |
200 | non-altitude | 1 |
201 | glyde | 3 |
202 | oxygen-free | 16 |
203 | difficult-to-see | 2 |
204 | crb-age | 2 |
205 | dose-age | 1 |
206 | starting-age | 1 |
207 | day-age | 3 |
208 | sex/age | 2 |
209 | two-cage | 1 |
210 | knowlege | 1 |
211 | no-sege | 1 |
212 | soche | 1 |
213 | psychopathic-like | 1 |
214 | decodable | 1 |
215 | deep-middle | 1 |
216 | double-burr-hole | 1 |
217 | fluorouracil-plus-levamisole | 1 |
218 | morphine-naltrexane | 1 |
219 | separate-vaccine | 1 |
220 | aminopyrrolidine | 1 |
221 | indolinooxazolidine | 1 |
222 | non-ranitidine | 1 |
223 | wortmannin+caffeine | 1 |
224 | inhibitors+caffeine | 1 |
225 | melatonin+amitriptyline | 1 |
226 | levantine | 3 |
227 | 'swine | 2 |
228 | betamethasone-alone | 1 |
229 | prednisone-alone | 1 |
230 | radon-prone | 4 |
231 | interslope | 1 |
232 | vaccine-wildtype | 1 |
233 | enterotype | 3 |
234 | nonprototype | 1 |
235 | sub-nanometre | 2 |
236 | medium-titre | 1 |
237 | medium-exposure | 1 |
238 | hydraulic-fracture | 1 |
239 | nonstricture | 1 |
240 | activity-structure | 1 |
241 | no-rupture | 1 |
242 | mixed-case | 1 |
243 | thyroglobulin-beta-d-galactosidase | 1 |
244 | guianese | 1 |
245 | nicobarese | 3 |
246 | non-diet/non-exercise | 1 |
247 | aldohexose | 2 |
248 | cold-climate | 2 |
249 | superordinate | 19 |
250 | sulfate/sulfonate | 1 |
251 | 3',5'-bisphosphorothioate | 1 |
252 | hydrate/hydrate | 2 |
253 | base-composite | 1 |
254 | once-remote | 1 |
255 | face-cue | 1 |
256 | removal-technique | 1 |
257 | stem-negative | 1 |
258 | contrast-negative | 1 |
259 | devastative | 1 |
260 | surface-reactive | 1 |
261 | t2wi-positive | 2 |
262 | non-incentive | 1 |
263 | cancer-suggestive | 2 |
264 | particle-size | 6 |
265 | pore-size | 1 |
266 | non-poaf | 2 |
267 | udca+bf | 1 |
268 | dcm-chf | 2 |
269 | placebo+oif | 2 |
270 | fsh-srf | 1 |
271 | vasculature/csf | 1 |
272 | no-z-buf | 1 |
273 | consag | 1 |
274 | between-pcg | 1 |
275 | ptx/gjg | 3 |
276 | 15.0-mg | 1 |
277 | 8.0-mg | 1 |
278 | 18/12-mg | 1 |
279 | non-sliding | 5 |
280 | passive-stretching | 1 |
281 | no-remodeling | 4 |
282 | yangming | 15 |
283 | web-training | 1 |
284 | dvd-training | 1 |
285 | nonhaptics-training | 1 |
286 | oxygen-containing | 17 |
287 | non-infarct-containing | 1 |
288 | high-staining | 1 |
289 | complementarity-determining | 6 |
290 | poor-planning | 1 |
291 | cetp-expressing | 2 |
292 | et-overexpressing | 1 |
293 | -donating | 2 |
294 | electron-donating | 30 |
295 | upward-pointing | 1 |
296 | non-caregiving | 1 |
297 | -withdrawing | 2 |
298 | electron-withdrawing | 59 |
299 | nonmedicalizing | 2 |
300 | exxxpg | 1 |
301 | antibody-drug | 20 |
302 | drugs/drug | 3 |
303 | 192-h | 1 |
304 | bshy-h | 6 |
305 | glutamine-rich | 3 |
306 | epoch-by-epoch | 1 |
307 | fpi+hh | 1 |
308 | non-hh | 1 |
309 | -so₂ch₂cooh | 2 |
310 | h+sh | 1 |
311 | rockfish | 3 |
312 | country-of-birth | 1 |
313 | non-sbi | 2 |
314 | no-bci | 1 |
315 | un-gi | 4 |
316 | hla-ii | 3 |
317 | capeiii | 1 |
318 | age-sex-bmi | 1 |
319 | pn/gpi | 2 |
320 | camopi | 1 |
321 | kizkalesi | 3 |
322 | non-futi | 1 |
323 | nonfeedback | 2 |
324 | high-recurrence-risk | 1 |
325 | low-middle-risk | 1 |
326 | dlsk | 7 |
327 | 10mgq8wk | 3 |
328 | clinical-roentgenological | 1 |
329 | geographical | 815 |
330 | economic-geographical | 1 |
331 | eco-geographical | 2 |
332 | phytogeographical | 2 |
333 | microanatomical | 1 |
334 | ethnical | 9 |
335 | semitropical | 2 |
336 | cultural/historical | 1 |
337 | bimusical | 2 |
338 | mid-intertidal | 4 |
339 | nasopharyngeal+oropharyngeal | 1 |
340 | matrilineal | 6 |
341 | acratopegal | 1 |
342 | cervical-facial | 1 |
343 | racial | 786 |
344 | ethnic/racial | 21 |
345 | ethnoracial | 6 |
346 | sub-superficial | 2 |
347 | para-mesangial | 1 |
348 | acidobacterial | 1 |
349 | hypogastrial | 1 |
350 | extravascular/interstitial | 1 |
351 | non-circumferential | 5 |
352 | latitudinal | 39 |
353 | urban-regional | 1 |
354 | indicational | 1 |
355 | seasonal | 1,479 |
356 | intradiurnal | 1 |
357 | hospital-referral | 1 |
358 | rural/non-rural | 1 |
359 | ethnocultural | 7 |
360 | antero-basal | 1 |
361 | connatal | 4 |
362 | fronto-tempero-parietal | 1 |
363 | varietal | 9 |
364 | perigenital | 4 |
365 | cervicomental | 2 |
366 | posterior-parietal-frontal | 1 |
367 | crenarchaeotal | 8 |
368 | no-clopidogrel | 1 |
369 | phylum-level | 3 |
370 | surgeon-level | 1 |
371 | outcomes-all | 1 |
372 | near-wall | 3 |
373 | target-cell | 2 |
374 | late-refill | 1 |
375 | 0.3-ng/ml | 1 |
376 | intermediate-flavanol | 1 |
377 | sirna-control | 1 |
378 | dc-control | 1 |
379 | diethylstibestrol | 1 |
380 | lophyl | 3 |
381 | alkoxyl-alkyl | 1 |
382 | 3-nitro-phenyl | 3 |
383 | styrenyl | 1 |
384 | levulinoyl | 1 |
385 | 5'-o-levulinoyl | 1 |
386 | thio-phen-2-yl-methyl-amino-n-propyl | 1 |
387 | 2,3-epoxypropyl | 7 |
388 | sulfydryl | 2 |
389 | tyrosyl | 13 |
390 | methoxyl | 15 |
391 | hydroxyl | 453 |
392 | '-hydroxyl | 1 |
393 | 5'-hydroxyl | 2 |
394 | 7-hydroxyl | 1 |
395 | cyclopentenylbenzyl | 1 |
396 | 2-chloro/cyanobenzyl | 1 |
397 | active-sham | 1 |
398 | 5×5-cm | 1 |
399 | mta/cem | 1 |
400 | sulfonamide-trimethoprim | 4 |
401 | uim | 5 |
402 | whole-organism | 6 |
403 | non-irsm | 1 |
404 | temporo-cerebellum | 1 |
405 | intra-urban | 7 |
406 | rural-urban | 17 |
407 | british-canadian | 1 |
408 | floridian | 1 |
409 | salian | 1 |
410 | southeast-asian | 1 |
411 | avian | 474 |
412 | wheat-bran | 3 |
413 | maiden | 4 |
414 | risk-aversion-gain | 1 |
415 | cingulate-brain | 1 |
416 | baffin | 2 |
417 | al-muta'allimin | 1 |
418 | esomeprazole-plus-aspirin | 1 |
419 | irradiation+neurotensin | 1 |
420 | diet-plus-pravastatin | 1 |
421 | carboxybiotin | 1 |
422 | nonexpansion | 1 |
423 | in-tension | 1 |
424 | sad-depression | 4 |
425 | rorγt-overexpression | 1 |
426 | non-transfusion | 1 |
427 | visual-association | 1 |
428 | oxygen-inhalation | 1 |
429 | cholesterol-modulation | 1 |
430 | nonreoperation | 1 |
431 | no-titration | 1 |
432 | needling-sensation | 1 |
433 | no-traction | 1 |
434 | non-transfection | 1 |
435 | 4-injection | 2 |
436 | no-suction | 1 |
437 | between-position | 2 |
438 | standard-solution | 2 |
439 | decathlon/heptathlon | 1 |
440 | no-iron | 1 |
441 | northern/southern/eastern/western | 1 |
442 | 'unknown | 2 |
443 | i-i-o | 2 |
444 | pregabalin/placebo | 1 |
445 | mtx+pbo | 1 |
446 | livedo | 14 |
447 | rando | 5 |
448 | dengego | 1 |
449 | piko | 2 |
450 | aerosol/no | 1 |
451 | molopo | 1 |
452 | nro | 1 |
453 | antemoro | 3 |
454 | para-nitro | 1 |
455 | metoprolol+iso | 1 |
456 | 8-to | 1 |
457 | kemerovo | 4 |
458 | dna-pva-p | 3 |
459 | n-tol-p | 1 |
460 | p-o-p | 1 |
461 | non-sleep | 11 |
462 | od+lp | 1 |
463 | ntlp | 1 |
464 | cee-mp | 1 |
465 | krg+3-np | 1 |
466 | boecop | 1 |
467 | 3-drop | 1 |
468 | triple-bar | 2 |
469 | nicobar | 14 |
470 | crossed-lamellar | 1 |
471 | non-appendicular | 1 |
472 | tetanus/diphtheria/acellular | 1 |
473 | hib/acellular | 1 |
474 | centro-acinar | 1 |
475 | perivascluar | 1 |
476 | age-gender | 13 |
477 | sex-gender | 3 |
478 | race/gender | 1 |
479 | responder/non-responder | 3 |
480 | normoresponder | 1 |
481 | non-bather | 1 |
482 | loop/linker | 1 |
483 | post-toddler | 1 |
484 | bonner | 1 |
485 | moderate-meat-eater | 2 |
486 | 18s/inter | 2 |
487 | seven-letter | 2 |
488 | no-fever | 1 |
489 | hay-fever | 1 |
490 | chx-mwsupra_ir | 1 |
491 | ir/cir | 1 |
492 | 600-mg-peramivir | 1 |
493 | scytonemin-poor | 1 |
494 | hrp-apr | 1 |
495 | ld-qiv-as | 1 |
496 | ld-tiv-as | 1 |
497 | post-acas | 1 |
498 | 3'-cs | 1 |
499 | indazole-3-carboxylates | 1 |
500 | tsallis | 3 |
501 | epidermis/hypodermis | 1 |
502 | mailed-materials | 1 |
503 | sandhills | 2 |
504 | flisvos | 1 |
505 | aa+lps | 1 |
506 | c3-ss | 1 |
507 | extubation-success | 3 |
508 | noseless | 1 |
509 | high-fss | 1 |
510 | inferior-umbilicus | 1 |
511 | hoemophilus | 2 |
512 | ethno-religious | 4 |
513 | scrc-mucinous | 1 |
514 | monocotyledonous | 8 |
515 | normal-proestrus | 1 |
516 | short-proestrus | 1 |
517 | hiv-status | 8 |
518 | within-day/between-days | 1 |
519 | azt-sys | 2 |
520 | wsd+t | 5 |
521 | cagn-3.0t | 5 |
522 | vegetal/fat | 3 |
523 | dpp+dt | 1 |
524 | fortified-diet | 1 |
525 | tented-leaflet | 1 |
526 | tbo/light | 1 |
527 | protein-deficit | 1 |
528 | three-transit | 1 |
529 | 120alt | 2 |
530 | hflt | 6 |
531 | no-qlt | 1 |
532 | non-pmt | 2 |
533 | five-implant | 1 |
534 | abutment/implant | 2 |
535 | immune-dominant | 2 |
536 | direction-dependent | 2 |
537 | adh-deficient | 1 |
538 | tsh-deficient | 2 |
539 | noradrenalin-deficient | 1 |
540 | hypoxic/nutrient | 1 |
541 | valent | 16 |
542 | physician-management | 1 |
543 | segment-to-segment | 3 |
544 | inter-segment | 6 |
545 | carvedilol-treatment | 1 |
546 | bisoprolol-treatment | 1 |
547 | tobramycin-treatment | 1 |
548 | low-treatment | 1 |
549 | cv-event | 2 |
550 | hct-rt | 1 |
551 | cyto-trophoblast | 1 |
552 | nontrophoblast | 1 |
553 | post-cst | 1 |
554 | intrapathologist | 1 |
555 | pianist | 1 |
556 | riper+ipost | 4 |
557 | kwt | 1 |
558 | 60,000-iu | 1 |
559 | 125-iu | 1 |
560 | vsv/hcv | 1 |
561 | non-niv | 1 |
562 | rostov | 1 |
563 | non-ipv | 2 |
564 | non-qv | 1 |
565 | inverted-view | 1 |
566 | bamhiw | 1 |
567 | 4kkw | 1 |
568 | third-row | 2 |
569 | pcw-bx | 1 |
570 | race-sex | 8 |
571 | age-sex | 30 |
572 | age/sex | 12 |
573 | actn3rx | 1 |
574 | 0.5y | 1 |
575 | 1.0-mg/kg/day | 2 |
576 | hemeroby | 1 |
577 | coh+zdy | 1 |
578 | ewey | 2 |
579 | 25-gy | 2 |
580 | inter-daily | 1 |
581 | non-epidemiologically | 1 |
582 | climatically/seasonally | 1 |
583 | ba-only | 1 |
584 | bmvc-only | 1 |
585 | mainstreamed-only | 1 |
586 | care-only | 1 |
587 | zn-only | 1 |
588 | sirolimus-only | 1 |
589 | pamphlet-only | 2 |
590 | sjhst-only | 1 |
591 | beverly | 2 |
592 | non-adrenalectomy | 1 |
593 | tam-plus-chemotherapy | 1 |
594 | nonchemotherapy | 5 |
595 | high-schizotypy | 1 |
596 | intact-ovary | 1 |
597 | postadvisory | 1 |
598 | within-country | 4 |
599 | language/country | 2 |
600 | intra-city | 3 |
601 | low-probability | 8 |
602 | quasiprobability | 1 |
603 | strength-intensity | 3 |
604 | income/poverty | 1 |
605 | sham-vertebroplasty | 1 |
606 | meth-oxy | 12 |
607 | ethyleneoxy | 2 |
608 | 6-carbethoxy | 1 |
609 | trimethoxy | 2 |
610 | propylenedioxy | 1 |
611 | aminoalkoxy | 2 |
612 | 2,3,6-trimethylphenoxy | 2 |
613 | 5,6-epoxy | 1 |
614 | alkylperoxy | 1 |
615 | 10-khz | 1 |
616 | 2-khz | 1 |
617 | ni₂₇₀₀ | 1 |
618 | ute₂ | 2 |
619 | tc® | 1 |
620 | dh-jh-eμ | 1 |